Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2024 Oct 24;17:17562864241286497. doi: 10.1177/17562864241286497

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s), 2024

This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).

PMC Copyright notice

Figure 4. — FACS analysis of neutrophils. (a) The number of neutrophils was significantly reduced in patients treated with sc. PEG-IFN-β-1a compared to healthy controls. (b) The neutrophils from patients under sc. PEG-IFN-β-1a shows significantly less CD62L in comparison to neutrophils from both healthy controls and sc. IFN-β-1a-treated patients. Neutrophils from patients treated with sc. PEG-IFN-β-1a displayed significantly more (c) CD15 and (d) HLA-DR than those from sc. IFN-β-1a-treated patients or healthy controls.

*p < 0.05. **p < 0.01.

FACS, fluorescence-activated cell sorting; IFN-β, interferon-beta.